Regulatory Strategy Development
Paper details:
A regulatory strategy for a potential and novel iron chelator therapy must be developed regarding orphan drug exclusivity AND pediatric exclusivity in BOTH the US and EU. See specific instructions attached. Kindly submit a draft before the deadline in order to assess it before and provide feedback.
